Bio-Synthesis

Executive Summary

Bio-Synthesis, Inc. is a well-established life science services company (founded 1984) based in Lewisville, Texas, specializing in custom synthesis and modification of oligonucleotides, peptides, and related biomolecules. With a focus on complex and modified sequences, including ultra-long nucleic acids, the company serves research, diagnostic, and therapeutic development clients. Its comprehensive suite of services encompasses large-scale synthesis, bioconjugation, and analytical support, positioning it as a reliable partner for both academic and industrial customers. The company's longevity and expertise in custom biomolecule synthesis provide a stable foundation for capturing growing demand from the biopharmaceutical sector, particularly as oligonucleotide and peptide therapeutics advance through clinical pipelines.

Upcoming Catalysts (preview)

• Q3 2026Expansion of GMP manufacturing capacity for oligonucleotide therapeutics70% success
• Q4 2026Strategic partnership with a major biopharma company for custom peptide synthesis60% success
• Q2 2026Launch of enhanced mRNA synthesis service utilizing novel modification chemistries80% success